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Maintenance Hemodialvsis 1008-129.224A 
Major Bleeding Incidence’After Coronary Artery Bypass 
Grafting in Patients With Unstable Angina/Non-ST 
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Abrogation of Apoptosis in Atherosclerotic Plaques: 
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C-Reactive Protein in Atrial Fibrillation: Evidence for the 
Presence of Inflammation in the Genesis and 
Perpetuabon of the Arrhythmia 1089-14.99A 
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Primates 836-l .371 A 
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Deceptive Ostial Coronary Lesions: Lack of 
Relationshto Between lmaaino and Phvsloloav 
1149.190&4A 
__ _. 
Effects of ACAT InhibitIon by Positron Emission 
Tomography Measured Myocardial Blood Flow: A 
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Participate in the Establishment of Membrane 
Potential and Cell Growth 1186-4.125A 
Extrinsic Rapid Electrical Stimulation Modulates 
Sarcoplasmic Reticulum Ca2+ Regulatory Proteins in 
Cultured Rat Cardiomyocytes 1132.131.276A 
IL-6 Is Produced by Splenocytes Dewed From 
CMV-Infected Mice in Response to CMV Antigens, 
and Induces MCP-1 Production by Endothelial Cells: 
A New Mechanistic Paradigm for Infection-Induced 
Atheroaenesis 1178-l 42.297A 
Prognoscc Value of Monocyte Cell Markers Early After 
Acute Myocardial Infarction 1194-l 01.394A 
Raloxifene Acutely Suppresses Ventricular MyoCyte 
Contractility Through Inhibition of the L-Type Calcium 
Current 1082151.254A 
Regulation of Estrogen Receptor Subtypes on Vascular 
Cells 107%136.269A 
Sex Differences rn the Response of Cardiac Myocytes 
to the Phytoestrogen, Genistein 1082-150.254A 
Transmural Action Potential Repolarization 
Heterogeneity Develops Postnatally in the Rabbit 
825.1.112A 
Tyrosine Kinases Inhibit Availability and Open 
Probability of Single L-Type Calcium Channels in 
Human Atrial Myocytes 1041-1490A 
Cells 
Acute Dynamic Exercise Increases Circulating 
Endothelial Progenitor Cells 117%137.296A 
Angiogenic Potential of Subcutaneous Adipose Stromal 
Cells for Autologous Cell Therapy 1201-l 52.306A 
Antifibrotic Prooertv of Brain Natriuretic Peotide in 
Cardiac Fib&blasts: Cross-Talk Action tiith 
Endothelin-I and Tumor Necrosis Factor on the 
Induction of Matrix Metalloproteinases 409-2.543A 
Biological Ex-Viva Pre Differentiation of Adult Bone 
Marrow-Derived Mesenchvmal Stem Cells for 
Cardiac Repair in a Chronic Dog Model of Myocardial 
Infarction 809.4.171A 
Bone Marrow Derived Cardiomyocytes Are Present in 
Adult Human Heart 410-1544A 
Combination of Mesenchymal Stem Cell 
Transplantation and Anqiogenic Gene Transfer for 
Myocardial Regeneration and Therapeutic 
Anaioaenesis 1185-86.208A 
Cons&ive Overexpression of Hypoxia Inducible 
Factor-laNP-16 Enhances the In Vitro Angiogenicl 
Arteriogenic Effects of Mesenchymal Stromal Cells 
630-3.279A 
Erythropoietin Augments Cardiomyocyte Survival and 
Left Ventricular Function After Hypoxia 
1196-113.399A 
First Experience With Noncavitational Ultrasound 
Enhancement of Selective Cellular Delivery of Liquid 
Perfluorocarbon Nanooarticles to Anaiooenic Sites 
1151-175.69A 
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Hammerhead Ribozymes Directed Against Cyclin E 
and E2Fl as Tools to Prevent InStent Restenosis 
1055-117.241A 
Impact of Autologous Skeletal Myoblast Transplantation 
on Hemodynamics and Left Ventricular Function in 
Repeated Coronary Microembolization-Induced 
Heart Failure in Awake Dogs 1135.84.161A 
Improvement in Global and Segmental Left Ventricular 
Contractility Following Autologous Bone Marrow Cell 
Transolantation in Humans With Severe lschemic 
Heart Failure 674-5.219A 
Improvement in Symptoms and Exercise Capacity at 
Eight Weeks in a Controlled Study of Autologous 
Bone Marrow Cell Transplant in Humans With Severe 
lschemic Heart Failure 823-1.44A 
Mechanisms Underlying the Putative Role of 
Transforming Growth Factor Beta-l in Pathological 
Collagen Deposition in Chronic Heart Failure 
1060-67.155A 
Noncultured Autologous Skeletal Muscle Cells Can 
Successfully Engraft in Ovine Myocardium 
1185~85.206A 
Overexpression of Tumor Necrosis Factor-a in 
Cardiomyocytes Migrates Embryonic Stem Cells 
865-3.313A 
Percutaneous Endocardial Versus Selective Coronary 
Venous Cellular Delivery: Comparisons of Transplant 
Efficrency, Distribution, and Efficacy in Reducing 
Infarct Size and Improving Myocardial Function 
1176-l 74.67A 
Real-Time Magnetic Resonance Imaging for Integrated 
Identification, Targeting, and Injection of Labeled 
Stem Ceils to Porcine Myocardial Infarction 
407.2542A 
Receptor Activator of NF-kB (RANK) and Its Ligand 
RANK-L Coincide With Expression of Rapamycin 
Receptor FKBP12 in Neointimal Dendritic Cells 
1031-173.14A 
Safety and Feasibility of Autologous Myoblast 
Transplantation in Patients Undergoing Coronary 
Artery Bypass Grafting: Results From the United 
States Experience 846FO-5.360A 
Safety of Autologous Bone Marrow Cell Injection in 
Humans With Severe lschemic Heart Failure 
1176-i 76.67A 
Site Specific Systemic Delivery of Rapamycin With 
Perfluorobutane Gas Microbubble Carrier Reduced 
Neointimal Formation in the Porcine Coronary 
Restenosis Model 1031-200.16A 
Statins Inhibit Calcification of Aortic Valve Interstitial 
Cells 1177.136.296A 
The Coronary Sinus: A Safe and Effective Route for 
Percutaneous Myoblast Transplantation 
1176-177.67A 
Transplantation of Autologous Endothelial Cells Induces 
Angiogenesis in a Sheep Model of Chronic lschemia 
1201-l 22.306A 
Ventricular Arrhythmias Following Autologous Skeletal 
Myoblast Implantation 11 IO-78.176A 
Central nervous system 
B-Type Natriuretic Peptide Predicts Cardiac Injury and 
Dysfunction After Subarachnoid Hemorrhage 
1062.61.166A 
Diastolic Dysfunction After Neurocardiogentc Injury: 
Prevalence and Association With Pulmonary Edema 
1207.85.214A 
lschemic Stroke Causes Regional Denervation in Rat 
Myocardium 1142.42.444A 
Markers of Central Modification of the Sympathetic 
Nervous System Activity in Humans 1115-l 1 .llOA 
Persistant Myocardial Sympathetic Denervation in 
Patients With Neurocardiogenic Injury 1142-43.444A 
Cerebrovascular circulation 
Vascular Disease Independently Predicts Worse 
Outcome After Percutaneous Coronary Intervention: 
Results From the NHLBI Dynamic Registry 
1005A-211.3A 
Cholesterol 
Atoivastatin Inhibits Aortic Valve Calcification in an 
Experimental Model of Chronic Hypercholesterolemia 
via Nonlipid Lowering Effects 824FO-2597A 
Blood Pressure, Weight, and Cholesterol 890-2.32OA 
Cholesteryl Ester Transfer Protein Variants Are 
Associated With Plasma Levels of High-Density 
Lipoprotein Cholesterol but Not the Severity or 
Progression of Coronary Atherosclerosis or 
Response to Therapy 1107-137.266A 
Endothelial and Hepatic Lipase Gene Polymorphisms 
Are Associated With Plasma Levels of High-Density 
Lipoprotein Cholesterol in Lipoprotein Coronary 
Atherosclerosis Study 1107.138.266A 
Enhanced Mobilization of Circulating Endothelial 
Progenitor Cells in Hypercholesterolemic Patients by 
3-Hydroxy-3-Methylglutaryl Co-A Reductase Inhibitor: 
View Point to Two Different Types of Endothelial 
Progenitor Cells 1131-138.27lA 
Improved Lipid Profile and Reduced Lipid Peroxrdation 
With Soy Milk in Patients With Primary 
Hypercholesterolemia 1057-150.244A 
Internet-Based Continuing Medical Education 
Instruction and Live Interactive CME Workshops 
Produce Similar Knowledge Gains of National 
Cholesterol Education Program: Adult Treatment 
Panel Ill Guidelines 1122-57.5264 
Mediterranean and Low Fat Diets Are Associated With 
Similar Lipid Levels at 12 Months in Patients With 
Coronary Heart Disease on Statrn Therapy 
1056.122.243A 
On-Line Detection of Cholesterol and Calcrfication by 
Catheter-Based Raman Spectroscopy in Human 
Atherosclerotic Plaque Ex Viva 1102-l 774OA 
On-Treatment Increments in Serum High-Density 
Lipoprotein Levels Are Associated With Improved 
Survival in Patients With Coronary Heart Disease: An 
Extended Follow-Up of the Bezafibrate Infarction 
Prevention Trial 876.3.316A 
Post-Prandial Lipid and Lipoprotein Responses in 
Patients Taking HIV Protease Inhibitors 
1057.149.244A 
Preventing Coronary Events by Control of Lrpids and 
Blood Pressure in Persons With the Metabolic 
Syndrome 1107.144.266A 
Relationship Between Serum Cholesterol Levels and 
Development of Arterial Hypertension in the 
Population of the Brisighella Heart Study 
1133.153.276A 
Stabilization of Plaque Size Accompanied by a Time 
Dependent Decrease in Activated Macrophage 
Content After Vascular Injury in the Apolipoprotein-E 
Null Mouse 1200.142.306A 
Statin Therapy Is Associated With Improved Survival in 
lschemic and Nonischemic Heart Failure 
1085.76.163A 
The impact of Moderate Elevations of Blood Pressure 
and Low-Density Lipoprotein Chlosterol on Coronary 
Heart Disease Risk 1107-140.267A 
The Relationship Between High-Density Lipoprotein 
Cholesterol and Vasomotor Function 1036-l 19.236A 
Theaflavin-Enriched Green Tea Extract Lowers 
Low-Density Lipoprotein Cholesterol 1057-146.243A 
Which Lipid/Lipoprotein Ratio Best Predicts 
Angiographic Coronary Artery Disease? 
1107-l 43.267A 
Cholesterol screening 
Prognostic Value of Simultaneous Assessment of Lipid 
and Inflammatory Markers in Patients With Stable 
Coronary Heart Disease 1036.153.236A 
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Cholesterol-lowering drugs 
Additive Benefits of Pravastatln and Asptrin to 
Decrease Risks of Cardiovascular Disease: 
Randomized and Observatronal Comparisons of 
Secondary Prevention Trials and Their M&r-Analysis 
1095.55526A 
Addltwe Effects of Ramipril and Atorvastatin on 
Inflammatory Cytokines Interferon-y, Tumor Necrosis 
Factor-a, lnterleukin-6. and C-Reactive Protein in 
Diabetic Patients With Congestive Heart Failure 
1181.123301A 
Additive Effects of Statin Combined With Angiotenstn 
Converting Enzyme Inhibitor on Vasomotion in 
Hypercholesterolemic Patients 1083-138.255A 
An Exammation of Atorvastatin Safety When Used in 
Combrnation With Verapamil: Evidence From 44 
Completed Clinical Trials 1026105336A 
Angiotensin Converting Enzyme Inhibition Reduces 
Elevated C-Reactive Protein rn Patients With 
Angiographic Coronary Artery Disease 
849FO-5.391A 
Atorvastatin Improves Myocardial Contractility in 
Moderately Hypercholesterolemtc Patients as 
Assessed by Tissue Doppler imaging During 
Dobutamkte Stress Echocardiography 1140.50442A 
Atorvastatin Inhibits Aortic Valve Calcification rn an 
Experimental Model of Chronic Hypercholesterolemia 
via Nonlipid Lowering Effects 824FO2507A 
Beneficial Effects of Statin Therapy in the 
Atherosclerotic Human Aorta Are Related to Plaque 
Locatton 811%3.259A 
C-Reactive Protein Is Reduced During Ezetimibe 
Coadministration With Simvastatin in Pattents With 
Primary Hypercholesterolemia 876~6316A 
Clinical Pathway Improves Acute Myocardial Infarction 
Quality Indicators 1191-45.366A 
Coadministration of Ezetimibe With Simvastatin 
1010.147.227A 
Correlation Between Statin Therapy Before 
Percutaneous Coronarv Intervention. Periorocedural 
Creatine Kinase-MB R&ease, and Mortality at 
Follow-Up 867-1.77A 
Diabetes and Progression of Coronary Calcium Score 
Using Electron Beam Tomography 
1190MP-170.456A 
Differential Effects of Statins on Hypercholesterolemic 
Patients With Metabolic Syndrome 645-4.292A 
Does Pretreatment With Statins Before Percutaneus 
Coronary Intervention Reduce Myonecrosis? 
10837 143.256A 
Early Short-Term Use of Atorvastatin and Pravastatin rn 
Patients Wrth Non-ST Elevatron Acute Coronary 
Svndrome: Chanqes of Hemostatrc Parameters 
li71-106.362A - 
Effect of Pravastatin on Low-Density Lipoprotein 
Particle Concentratron as Determined by Nuclear 
Magnetic Resonance Spectroscopy: Results From 
the Pravastatm InflammationlCRP Evaluation 
(PRINCE) Trial 1010.150.226A 
Effects of Switching to Rosuvastatin From Atorvastatin 
or Other Statins on Achievement of International 
Low-Density Lipoprotein Cholesterol Goals: 
MERCURY I Trial lOlO-149.227A 
Efficacy and Safety of Pravastatin at 80 mg and 160 mg 
1010.151.226A 
Elevated Soluble Tumor Necrosis Factor Receotor 
Levels in Nonobese Adults With the Atherogonic 
Dyslipoprotememia 1156-l 18.29OA 
Enhanced Mobilization of Crrculatlng Endothekal 
Progenitor Ceils tn Hypercholesterolemtc Patients by 
3-Hydroxy-3-Methylglutaryl Co-A Reductase Inhibitor: 
Vtew Pomt to Two Different Types of Endothelial 
Progenitor Cells 1131-l 38.271 A 
Ezetimibe Coadmwtistered Wrth Atorvastatin Compared 
to Atorvastatin Alone rn the Attatnment of 
Low-Density Lipoprotein Goals Among High-Risk 
Patlents With Hypercholesterolemia 1083.140.255A 
Ezetimibe Coadministered With Low Dose Statins in 
Primary Hypercholesterolemia: Lipid Profiles 
Comparable to High-Dose Statin Monotherapy 
1083-142.255A 
Heterozygous Familial Hypercholesterolemia: 
Coadminrstration of Ezetrmibe Plus Atorvastatin 
1083.141.266A 
Increase I” Rusk Assoctated With a Statln Therapeutic 
lnterchanqe Policv 1095-52526A 
Lipid-LowerTng Therapy With Pravastatin Reduces 
Coronary Plaque Volume: Role of High-Densky 
Lipoprotern Cholesterol Containing Apolipoprotein 
A-l 1177.135.296A 
Patrents After Acute Mvocardial Infarction Have for a 
Prolonged Penod Increased Thermal Heterogeneity 
in Culorit Atherosclerotic Lessons: Additional Effect of 
Statins on Plaque Stabilizatron 1010.148.227A 
Pleiotropic Hemodynamic Action of Statins rn Rats 
Rendered Hypertenswe by lnhibrtion of Nrtric Oxide 
Synthew 832.4.261A 
Predictors of Clinrcal Outcome in Patients Undergoing 
Penpheral Vascular Interventions: Insights From the 
University of Michtgan Peripheral Vascular Disease 
Quality Improvement Initiative (PVD-Ql2) 
1199-17575A 
Safety Efficacy, and Effect on Glucose Levels of 
Once-Dailv Niacin on Patients With Dvsliordemia 
1057.222.246A 
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Simvastatin Preserves Myocardial Function by 
Enhancing Endothelial Nitric Oxide Production in 
Heart Failure 1039-59.151A 
Srmvastatin Restores Contractile Function and 
Reduces Cardiac Remodeling in a Genetic Model of 
Cardiomyopathy 1135-60.16OA 
Six-Month Mortality Rates Are Lower in Patients With 
an Acute Coronary Syndrome Treated With the 
Combtnation of Clopidogrel and a Statin Than in 
Patients Treated With Either Therapy Alone: An 
Analysts From the Global Registry of Acute Coronary 
Events 822-3.361A 
Statln Therapies for Elevated Liprd Levels Compared 
Across Dose Ranges to Rosuvastattn: Low-Density 
Lipoprotein Cholesterol and High-Density Lipoprotein 
Cholesterol Results 876-2.315A 
Statin Therapy Is Associated With Improved Survival in 
lschemic and Nonischemic Heart Failure 
1085.76.163A 
Statins Potentrate the Anticoagulant Effects of Low 
Molecular Weight Heparin 1083-144.256A 
Statins Promote Systemic Antioxidant Effects Through 
Specific Inflammatory Pathways 1181.120.301A 
The HMG-CoA Reductose Inhibitor Atorvastatin 
Prevents Atrial Fibrillation by Inhibiting Inflammation 
in the Canine Sterile Pericarditis Model 1041.1566A 
Tracking Changes in Human Carotid Atherosclerosis 
Using Maqnetic Resonance lmaqina 
119OMP-i71.466A 
_ _ 
Variability in the ABCAI Gene but Not HMG-CoA 
Reductase Predicts Low-Density Lipoprotein 
Lowering Effects of Statins 1083.145.256A 
Circadian rhvthm 
Administration-Time Dependent Effects of Asprrin on 
Blood Pressure tn Untreated Hvpertensive Patients 
1009-l 54.227A 
Circadian Fluctuations in Thrombogenicity in Patients 
Undergoing Primary Angioplasty for Acute Myocardial 
Infarction 1172.92.364A 
Circadian Variation of Blood Pressure in Normotensive 
and White Coat Hypertensive Subjects 
1058-l 29.247A 
Circadian Variation of Plaque Rupture in Patients With 
Acute Myocardial Infarction 1102.185.42A 
Circardian Vanation of QT Dispersion Determined by 
Twelve-Lead Holler Electrocardiography in Patients 
Without Coronarv Arterv Disease 1213.9.135A 
Differences in Outcome oi Primary Angioplasty for 
Acute Myocardial Infarction Dunng Routine Duty 
Hours Versus During Cff-Hours: Is It the Patrent or Is 
It Care? 1097.96.367A 
Evaluation of the Extent and Duratron of the ABPM 
Effect in Patients With Essential Hypertension 
1058.128.246A 
Influence of Chronobiological Variation in the Rusk of 
Acute Aortic Dissection on In-Hospital Mortality 
1154s144.266A 
Prior Treatment With Anqiotensin Convertino Enzvme 
lnhrbitors Influences the Diurnal Variation% Acute 
Mvocardial Infarction Onset 1035-148.237A 
The Circadian Variation of Atrial Defibrillation 
Thresholds 1139~17.116A 
Clinical laboratorv information evetems 
High Body Iron Stores Predispose for Early Vascular 
Modifications in B-Thalassemia Maior Patients 
1033-l 34.234A 
Clinical trials 
Helicobacter Pylori Eradicatton Improves Prognosis of 
Coronary Artery Disease Through a Mechanism Not 
Related With Platelet Activation 1173.89.366A 
A Prospective Randomized Multicenter Trial Comparing 
Distal Protection During Saphsnous Vein Graft 
Intervention With a Filter-Based Device Compared to 
Balloon Occlusion and Aspiration: The FIRE Trial 
820.4.43A 
A Prospective, Randomized Trial of 
Thromboatherectomy During Intervention of 
Thrombotic Native Coronary Artenes and Saphenous 
Vern Grafts: The X-TRACT Trial 820-l 43A 
A Randomized Study of Three Tilt Test Protocols Wrth 
Lonq-Term Follow-Uo bv lmolantable Looo Recorder 
109&20.102A . 
A Simple ECG Method Using High-Risk Infarct Territory 
Is Superior to ECGs Using Summed ST Elevation for 
Assessing Risk rn ST El&on Myocardral Infarction 
872.4.402A 
Administration-Time Dependent Effects of Asprrin on 
Blood Pressure in Untreated Hyoertensw Patrents 
1009.154.227A 
An Optimal Diagnostic Threshold of Minrmum Stent 
Area to Predict Long-Term Stent Patency Following 
Sirolimus-Elutrnq Stent Imolantation: Serial 
Intravascular VI&sound Analysis From the SIRIUS 
Trial 877-l .60A 
Antibody Levels Against Chlamydia Pneumomae and 
Outcome of Roxithromycin Therapy: Results From a 
Substudy of the Randomized Antibtotic Therapy in 
Acute Myocardial Infarction (ANTIBIO) Trial 
1196-i 11.399A 
Assocration of Major Bleeding With Adverse Clinical 
Outcomes and Length of Stay: A TACTICS TIMI 18 
Substudy 1146-108.375A 
Baseline Features and Clinical Results in Patients 
Excluded From Randomization From a Large 
lnternattonal Trial of Reperfusion Strategies in Acute 
Myocardial Infarction: The CADILLAC Registry 
827-2.366A 
Blinded Adjudication of Reinfarctron Following 
Fibrinolysis: Data From the HERO-2 Trial 
1146-l 10.375A 
C-Reacttve Protein Is Reduced During Ezetimrbe 
C&administration With Simvastatin rn Patients With 
Primary Hypercholesterolemia 676.6.316A 
Cardiovascular Safety of Vardenafil in Patients 
Receiving Antihypertensive Medications: A Post-Hoc 
Analysis of Five Placebo-Controlled Clinical Trials 
1133.148.276A 
Case-Base Distance Measurements for the Selection of 
Controls in Case-Matched Studies: Application in 
Coronary tnterventions 1023.52.519A 
Changes rn Plasma Brain Natriuretic Peptrde and 
Norepinephnne Over Time and Subsequent Mortality 
and Morbidity in Heart Failure: Results From 
Val-HeFT 8864.222A 
ClInical Features of Minority Patients in the AFFIRM 
Study 1210-20.130A 
Clinicat Outcome After Prehospital Thrombolysis 
Versus Percutaneous Coronarv Intervention for ST 
Elevation Myocardial Infarction: Results of the START 
in Berltn Pilot Study 1197.194.72A 
Clinical Performance of the WaveletTM Automatic 
Electrogram Template Collection Algorithm 
1139.13.116A 
Coadministration of Ezetimibe With Simvastatin 
1 OlO-147.227A 
Correlates of Qualitv of Life in Advanced Heart Failure: 
Insights From the-Acorn Trial 1206.76.212A 
Cost-Effectiveness Analvsis of a Disease Manaaement 
Program in Chronic Heart Failure: DIAL Trial-r 
G.E.S.I.C.A. Investigators 1022MP-164.517A 
Cost-Effectiveness of Strolimus Druo-Elutina Stents for 
the Treatment of Complex Coronary Stenoses: 
Results From the Randomized SIRIUS Trial 
805.2.32A 
Cryoablatron for Treatment of Paroxysmal Atrial 
Fibrillation: Initial Results of a Prosoective Multicenter 
Clinical Trial 846-5.126A 
Cutting Balloon Atherotomy Is Associated With 
Decreased Stent Utilization 1149-191.65A 
Does a 3-D Strain Analysis Invalidate 2-D Strain? 
Observations rn Hypertensive Left Ventricular 
Hypertrophy From the LIFE Trial Using Magnetic 
Resonance Imaging 101 l-138.229A 
Does the Extent of ST-Segment Depression Predict 
Short- and Long-Term Mortality in Patrents With 
Non-ST Segment Elevation Acute Coronary 
Syndromes? Insights From the GUSTO IV 
822.1.360A 
Does the Magnitude of the Beneficial Effect of 
Beta-Blockers in Chronrc Heart Failure Differ 
Between Diabetic and Nondiabetic Patients? A 
M&a-Analysis of All-Cause Mortality Outcomes From 
Major Chronic Heart Failure Beta-Blocker Trials 
1085-77.163A 
Early Use of Beta-Blockade tn Complicated Myocardial 
Infarctton: The VALIANT Trial 1001.106.322A 
Effect of Carvedilol on Major Cardiovascular Events tn 
Post-Infarction Patients Treated With Angtotensin 
Converting Enzyme Inhibitors: Further Analysis of the 
Capricorn Trial 1071-l 13.346A 
Effect of Ethnicity on Distrust Toward Medical 
Researchers and Willingness to Join a 
Cardiovascular Drug Prevention Tnal 851-i .534A 
Effect of Roxithromyctn on Clinical Cardiovascular 
Events in Patients Undergoing Coronary Angioplasty 
1026-l 00.3364 
Effects of Avasimibe in Claudicants With Peripheral 
Arterial Disease 857.4.304A 
Efficacy and Safety of a Chronotherapeutic 
Graded-Release Diltiazem Hydrochloride 
Formulation Dosed at Bedtime Compared to Placebo 
and to Morning Dosing in Chronic Stable Angina 
Pectoris 1026-l 02.3354 
Efficacy of a Novel P-Selectin Antagonist, rPSGL-Ig for 
Reperfusion Therapy in Acute Myocardial Infarction: 
The RAPSODY Trial 881 FO-4.404A 
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Sildenafil Improves Left Ventricular Systolic Function in 
Patients With Conaestive Heart Failure: The Role of 
Wave Reflections 7 105-l 54.264A 
Stem or Percutaneous Transluminal Coronary 
Anaioplastv for Occluded Coronaw Arteries in 
Pat;ehts With Acute Myocardial Infarction Ineligible for 
Thrombolvsis (STOPAMI-3) Trial 1172-96365A 
Superior Efiicacy of Low Molecular Weight Heparin 
Versus Unfractionated Heparin in Acute Coronary 
Svndromes Without ST Elevation 1171-108.362A 
Mesenchymal Stromal Cell Transplantation Contributes 
to Collateral Response in Tissue lschemia Through 
Release of Arteriogenic Cytokines 1176173.67A 
Nicorandil Preserves Collateral Circulation Even at 
Reduced Systemic Pressure in Comparison With 
Nitroglycerin: Real-Trme Myocardial Contrast 
Echocardiographic Study 1043.50.414A 
TNFa and IL-6 Release During Primary Percutaneous 
Coronary Intervention for Acute Myocardial Infarction 
Is Related to Coronary Collateral Flow 
1123-108.362A 
Elective Coronary Angioplasty and Percutaneous 
Coronary Intervention During Uninterrupted Warfarin 
Theraov 1174-190.63A 
Ezatimibe Coadministered Wrth Low Dose Statins in 
Primary Hypercholesterolemia: Lipid Profiles 
Comparable to High-Dose Statin Monotherapy 
1083-I 42.255A 
Heterozygous Familial Hypercholesterolemia: 
Coadministration of Ezetimibe Plus Atorvastatin 
1083.141.256A 
Hypertension Adverse Experiences Among 
Osteoarthritis Patients Treated With Rofecoxib, 
Celecoxib. or Acetaminophen in the VACT Trials 
1203-123.31OA 
Intection of Monteplase Prior to Percutaneous Coronary 
Intervention Maintains Left Ventricular Function and 
Prevents Left Ventricular Remodeling rn Acute 
Myocardial Infarction Combining Monteplase With 
Angioplasty: COMA Trial 1191.28.367A 
Internet-Based Continuing Medical Education 
Instruction and Live Interactive CME Workshops 
Produce Similar Knowledge Gains of National 
Cholesterol Education Program: Adult Treatment 
Panel Ill Gurdelines 1122.57.626A 
Is There Risk Associated With the Use of Nesrritide for 
Acute Heart Failure? 1085.70.16lA 
lschemia Modified Albumin: A New Biomarker of 
Myocardial lschemia for Early Diagnosis of Acute 
Coronary Syndromes 1048-9734OA 
Niacin Decreases Myocardial Infarctron and Total 
Mortality in Patients With Metabolic Syndrome: 
Results From the Coronary Drug Project 
845-2.29lA 
Occurrence of Transient ST-Segment Elevation During 
Pulmonary Vein Ablation for Paroxysmal Atrial 
Fibrillation in a Prospective Multi-Center Study 
1063-16.95A 
Overlapping Sirolimus-Eluttng Stems: Intravascular 
Ultrasound Analysis From the SIRIUS Trial 
877~5.81A 
Performance of the Thrombolysis in Myocardial 
Infarction Risk Index for Early Acute Coronary 
Syndrome rn the National Registry of Myocardial 
Infarction: A Sample Risk Index Predrcts Mortality in 
Both ST and Non-ST Elevation Myocardial Infarction 
112596.366A 
Pharmacodynamics of Eptifibatrde and Abcrximab in 
Patients With Non-ST Segment Elevation Acute 
Coronaw Syndromes (TAMP) 1124.89.363A 
Tumor Necrosrs Factor Sianalina Not lmoortant for 
TheAssociation of the Heart Failure Score With 
Mortality and Hospitalizatrons in Pacemaker Patlents 
837.2.189A 
The Cyclooxygenase-2 Specific Inhibitor Valdecoxib Is 
Not Associated With an Increased Risk of 
Cardiovascular Thrombotic Events in Arthritis 
Patients 1095-51.525A 
Arteriogenesis but for A%giog&esis i201-153,306A 
Vascular Endothelial Growth Factor Induces Both 
Angiogenesis and Arteriogenesis Independently of 
Nitric Oxide 830.6.26OA 
Computer communication networks 
Divx Compression Allows Medically Lossless lntranet 
or Internet Exchange of Coronary Angiograms 
866-4.538A 
Monitoring and Improving Hypertension Using the 
Veterans Administration Electronic Medical Record: A 
48-Month Review 1058.127.246A 
Practice lmoact and Patient Acceptance of a 
Cardiologist- Operated Web-Based Billing, Coding, 
and Reoort Generation Svstem 866-l .637A 
The Medicine, Angioplasty, or Surgery Study (MASS II 
Registry): A Comparison of Diabetic and Nondiabetic 
Patient’s Outcome in Medical Therapy, Coronary 
Angioplasty. and Bypass Surgery During the First 
Year Follow-Up 1050-I 05.345A 
The RelatIonship Between B-Type Natriuretic Peptide, 
Heart Structure, and Function in 4,300 Patients With 
Heart Failure Enrolled to Val-HeFT 888-2.221A 
The Use of Implantable Loop Recorders in the 
Diagnosis and Management of Syncope 
1090-3.199A Validation of Teleauscultatidh oh ah Internet-Based 
System 1122.54528A 
Wireless (GPRS-Based) Mobile Real-Time Patient 
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1065.77.163A 
Effects of Fenoflbrate on Transcription of DNA Variants 
at 5’ Untranslated Region of Human Apolipoprotein 
A-l Gene 1056-l 19.242A 
Effects of Growth Hormone Therapy Following Pediatnc 
Cardiac Transplantation 1137.65.166A 
Effects of Hypoglycemic Therapy on Survival in Patients 
With Type 2 Diabetes Mellitus and Coronary Artery 
Disease After Major Noncardiac Surgery 
1035-l 49.237A 
Efficacy and Safety of a Chronotherapeutic 
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Enhancement of Selective Cellular Delivery of Liquid 
Perfluorocarbon Nanoparticles to Angiogenic Sites 
1151.175.59A 
Hypertension Adverse Experiences Among 
Osteoarthritis Patients Treated With Rofecoxib. 
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832-l .260A 
Sildenafil Selectively Improves Endothelium-Dependent 
Microcirculation 1131.135.27lA 
Site Specific Systemic Delivery of Rapamycln With 
Perfluorobutane Gas Mlcrobubble Carrier Reduced 
Neointimal Formation in the Porcine Coronary 
Restenosis Model 1031.200.16A 
Specific Dysregulation of Troponins and Inflammatory 
Marker Genes in Endomyocardial Biopsies From 
Heart Transplant Recipients 1185-87.209A 
Spironolactone Improves Endothelial Function in 
Congestive Heart Failure Patients on Angiotensin 
Converting Enzyme Inhibitors 1177-i 32.295A 
The A376G (A+) Variant of the Glucose-B-Phosphate 
Dehydrogenase Gene Is Associated With Endothelial 
Dysfunction in African Americans 1079-131.249A 
The Beneficial Effect of Optimized Neurohormonal 
Therapy on Exercise Capacity in Heart Failure 
Patients Is Associated With the Restoration of 
Endothelial Function 1206.81.213A 
The Effect of Exercise Training on Endothelial Functw 
in Coronary Artery Disease: Role of Nitric Oxide and 
Endogenous Antioxidants 1104.148.262A 
The Effect of Exercise Training on the Endothelial 
Function of Coronary Artery in Patients With 
Myocardial Infarction 1161-67.199A 
The Molecular Mechanisms of Calcium Dependent 
Tissue-Type Plasminogen Activator Release 
1032-122.231A 
The Relationship Between High-Density Lipoprotein 
Cholesterol and Vasomotor Function 1036.119.236A 
The Role of Endothelial-Derived Hyperpolarizing Factor 
in Tissue-Type Plasminogen Activator Release 
1032.131.233A 
Time Course of Stent Endothekalization After 
Intravascular Radiation Therapy 112%181.48A 
Transcriptional Profiling of the Vascular Smooth Muscle 
Cell Response to Allograft Injury 855-4.210A 
Transplantation of AUtOlOQOUS Endothelial Cells Induces 
A”QiOgs”eSiS in a Sheep Model of Chronic lschemia 
1201-l 22.306A 
Tumor Necrosis Factor-a lmpaws 
Endothelium-Dependent Vasodllatation and 
Stimulates Local Tissue Plasminogen Activator 
Release in Humans: Diverse Vascular Actions of a 
Pleiotropic Cytoklne 856.3.302A 
Tumor Necrosis Factor-a Infusion Impairs Endothelial 
Function and Induces Endothelial and Metabolic 
Insulin Resistance in Humans 856-2.302A 
Upregulation of Arginase Mediates Endothelial 
Dysfunction in Aging Blood Vessels 
1130MP-171.270A 
Endothelium-derived relaxing factor 
Differential Effects of Cyclooxygenase and Nitric Oxide 
Inhibition on Endothelium-Dependent Responses in 
Coronary Arteries From Juvenile and Adult Male Pigs 
1155.148.289A 
Hemodynamic Effects of Aqueous Nitric Oxide 
Solutions Applied Directly Into Human Coronary 
Circulation 1131-l 40.272A 
Metformln Improves Endothelial Function I” Patients 
With Metabolic Syndrome X 1035.146.236A 
Raloxlfene Effect on Endothelial Function Depends on 
Duration of Menopause and Previous Hormone Use 
1035-l 47.236A 
Role of Endothelial Nitric Oxide Synthase in Arterial 
Remodeling in Heart Fallwe 1096-l 12.355A 
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The Role of Endothekal-Dewed Hyperpolarizing Factor 
rn Tissue-Type Plasmmogen Activator Release 
1032.131.233A 
Energy metabolism 
Acute intravenous Ranolazine Improves Left Ventricular 
Functton in Dogs With Heart Failure: A Dose 
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Conditional-Dependent Effects of CVT-4325. a Novel 
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Matrix Metalloproteinase Inhibition in Transgenic Mice 
With Modified Cardiac Restricted Tumor Necrosis 
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Geometry and Function 809-2.17OA 
Matrix Metalloproteinases and Their Inhibitors in 
Premature Coronary Atherosclerosis: Relation With 
Inflammation and Metabolrc Markers 640.3.262A 
PAPP-A. ProMBR and PAPP-AIProMBP Ratio Are 
Related to the Extent of Angiographfc Coronary 
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Increased Levels of Matrix Metalloproteinass-3 in 
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Correlation With C-Reactive Protein 1194-99.394A 
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Congenital Heart Disease: Prevalence Rates in a 
Population of 5,363,695 Adults 1192156.490A 
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1072-I 03.349A 
Decreasing One-Year Mortality From Heart Failure in 
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Registry-1988 to 2000 637-6.198A 
Does the Prevalence of Atria Fibrillation Vary by Race 
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(EPOCH) Study 1038-74.149A 
Effect of Ethnicity on Distrust Toward Medical 
Researchers and Willingness to Join a 
Cardiovascular Drug Prevention Trial 851-I .534A 
Increase in Mortality of Patients Discharged With the 
Diagnosis of Acute Myocardfal Infarction Between 
1986and 1996 1126.100.366A 
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Hazardous Waste Sites 1143-156.485A 
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N-T Pro-BNP and the Diagnosis of Heart Failure: A 
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Studres 1013.80.143A 
Rates of Diagnosis of Acute Myocardral Infarction 
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Cardiac Autonomic Modulation by Estrogen in Female 
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Electrophys&$ Testing 821.4.lllA 
Estradiol Coated Stems for the Prevention of 
Restenosis in Native Coronary Arteries: Results From 
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1150-l 79.56A 
Estrogen Augments Incorporation of Bone 
Marrow-Derived Endothelial Proaenitor Cells Into 
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Estrogen Is Vasoprotective in Osteopontin Deficient 
Mice 1031-176.15A 
Estrogen Receptor Alpha Gene Polymorphism Is 
Associated With Coronary Artery Disease Severity 
1033-139.235A 
High Endogenous Estrogen Levels Are Predictive of 
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Elderly Postmenopausal Women 1162-86.201 A 
Plasma C-Reactcve Protein Is Not Elevated in 
Physically Active Postmenovausal Women Taktno 
Hormone Replacement Therapy 840.5.263A _ 
Raloxifene Effect on Endothelial Function Deoends on 
Duration of Menopause and Previous Hormone Use 
1035-I 47.236A 
Regulation of Estrogen Receptor Subtypes on Vascular 
Cells 1079.136.250A 
Testosterone Aggravates Cardiac Performance and 
Remodeling in Mice After Myocardial Infarction 
809.3.170A 
Effect of Ethnicity on Distrust Toward Medical 
Researchers and Willingness to Join a 
Cardiovascular Drug Prevention Trial 851-I .534A 
Exercise 
Acute Dynamic Exercise Increases Circulating 
Endothelial Progenitor Cells 1178-137.296A 
Assessment of Left Ventricular Diastolic Function 
Following Completion of a Marathon in a Group of 
Well-Tratned Runners 1161-66.199A 
Autonomic Effects on Heart Rate Recovery in Patients 
With Coronary Artery Disease 1087-63.167A 
Cardiovascular Effects of the Endogenous Nitric Oxide 
Synthase Inhibitor Asymmetric Dimethylarginine 
(ADMA) and Evidence for ADMA Metabolism in 
Humans In Viva 856.5.303A 
Chronotrooic Resoonse to Exercise in Patients With 
Peripheral Arterial Disease Without Classical 
Symptoms of Intermittent Claudtcation 
1081.119.252A 
Effects of Acute Exercise on the Fibrtnolytic and 
Coagulative System in Patients With Chronic 
lschemic Heart Disease Ill i-66.176A 
Evidence of Impaired Left Atrial Function Response to 
Exercise in Hypertrophic Cardiomyopathy Patients 
With Heart Failure 1136-82.165A 
Exercise-induced Expression of Angiogenic Cytokines 
in Normal and Infarcted Hearts 1161.64.199A 
Feasibility of Exercise Rubidium-62 Positron Emrssion 
Tomography Myocardial Perfusion Imaging 
1093-38.428A 
Fitness Versus Activity for Predicting Mortality in Men 
838-3.191A 
High Prevalence of Anxiety rn Coronary Patients With 
Marked Improvements Following Cardiac 
Rehabilitation 1161-65.199A 
Impact of Obesity on Inflammation and Metabolic 
Svndrome in Coronarv Patients and Effects of 
Cardiac Rehabilitation Ill I-63.177A 
Importance of Diastolic and Systolic Hypertensive 
Response to Exercise on Left Ventricular Mass and 
Geometry 1209-63.217A 
Metabolic and Hemodvnamic Parameters Do Not 
Predict Sleep Disordered Breathing in Severe Stable 
Heart Failure 1061-78.156A 
Physrcal Activity Exerts Benefits in Coronary Heart 
Disease Through Autonomic Nervous System 
Modulation Ill I-65.178A 
Physical Training-Induced Reduction of Peripheral 
Monocyte-Related Inflammatory Markers Is 
Associated With Improvement in Endothelial Function 
of Chronrc Heart Failure Patients 1209-61.216A 
Plasma C-Reactive Protein Is Not Elevated rn 
Physically Active Postmenopausal Women Taking 
Hormone Replacement Therapy 840.5.263A 
POStDrandiaf Lipaemia-Induced Endothelial 
Dysfunction’The Protective Effects of High-Density 
Lipoprotein Cholesterol and Aerobic Fitness 
1130MP-189.269A 
Pulse Pressure at Early Stages of Exercise Predicts 
Angiographically Determined Coronary Artery 
Disease Severity 1161.60.196A 
Relationship Between Doppler-Derived Left Ventricular 
Filling Parameters and Exercise Capacity in Patients 
With Hypertrophic Cardiomyopathy 1044.35.414A 
Reported Health Behaviors Long-Term After Coronary 
Artery Bypass Surgery Compared With the General 
Population 1047-58.523A 
Skeletal Muscle Remodeling and Exercise Intolerance 
in Elderly Patients With Diastolic Heart Fatlure 
1088.87.166A 
The Effect of Exercise Trainrng on Endothelial Function 
in Coronary Artery Disease: Role of Nitric Oxide and 
Endogenous Anttoxidants 1104-148.262A 
The Effect of Exercise Training on the Endothelial 
Function of Coronary Artery tn Patients With 
Myocardial Infarction 1161.67.199A 
The Effects of Exercise on Lower Extremity Functtoning 
in Peripheral Arterial Disease Patients Without 
Intermittent Claudication: A Randomized Controlled 
Clinical Trial 857.3.394A 
Tissue Doppler Derived Index (EIEa) Correlates With 
Exercise Capacity in Patients With Hypertrophic 
Cardiomyopathy 1044-36.415A 
Tissue Doppler Imaging Is Superior to Mitral Flow 
Velocities for Predicting Exercise Performance 
1038.79.150A 
Upper Limits and Clinical Stgnificance of Left Atrium 
Dilatation in Trained Athletes 807-4.169A 
Exercise tests 
A Novel Periodic Breathing Index in Awake Patients 
With Heart Failure Predicts Prognosis 1062-88.161A 
Abnormal Peripheral Thermoregulatory Response to 
Exercise Substantially Impairs Exerctse Tolerance 
Among Patients With and Without lschemia on 
Myocardial Perfusion Srngle-Photon Emission 
Computed Tomography 111 I-60.177A 
Akin&a Becoming Dyskinesta During Exercise 
Echocardiography: Prevalence and Relationship to 
Clmical Outcome 1019.32.408A 
Anomalous Origin of the Left Coronary Artery From the 
Pulmonary Trunk: A 25Year Single Institution 
Outcome Study Following Surgical Restoration of 
Dual Coronary Antegrade Flows 1046.160.476A 
Association of Abnormal Heart Rate Recovery and 
Chronotropic Incompetence Wiih Obesity in a Healthy 
Cohort 838.6.191A 
Association of Abnormal Heart Rate Recovery 
Following Exercise Testing and Chronic Obstructive 
Lung Disease 1087-64.167A 
Better Functional Status Among U.S. Than Non-U.S. 
Patients After Percutaneous Coronary Intervention: 
An Effect of Medical Care? 1047-53.521A 
Blood Pressure Response During ABPM and Exercise 
and Cardiac Alternations 1058.130.247A 
Can a Pre-Exercise Test Score Predict Prognosis tn 
Women With a Low Prevalence of Coronary 
Disease? The National Heart, Lung, and Blood 
Institute-Sponsored Women’s lschemia Syndrome 
Evaluation (WISE) Study 838.4.191A 
Cardiopulmonary Exercise Capacity Increases in 
Patients Wtth Atrial Septal Defect Following 
Transcatheter Closure 1021-161.474A 
Clopidogrel Inhibits Exercise-Induced lschemia and 
Platelet Activatfon in Stable Coronary Artery Disease 
829.2.370A 
Comparison of Health-Related Quality of Life (SF-36) 
With Exercise Testing in Patients With Congenital 
Heart Disease 1192-156.490A 
Correlation of Bran? Natriuretic Peptide Release, 
Cardiopulmonary Exercise Testing, and Six-Minute 
Walktng Test in Patients With Heart Failure and 
Cardiac Resynchronization Therapy 1209.60.216A 
Dobutamine Nuclear Myocardial Perfusion Imaging 
Compared to Dobutamine Stress Echocardiography 
as a Prognostic Test for Coronary Artery Disease 
1020-42.411 A 
Doppler Stress Pulmonary Hemodynamics in Mild to 
Moderate Pulmonary Hypertension 1066-31.420A 
Dynamic Diastologic Stress Echocardiography With 
Mintmal Exercise Enables Prediction of Exercise 
Tolerance in Patients With Congestive Heart Failure 
1066.34.421A 
Early Repolarization, Heart Rate Recovery, and Rusk of 
Death 838-1.1984 
Effects of Avasimibe in Claudicants With Peripheral 
Artenal Disease 857.4.304A 
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Restrictive Characteristics of the Systemic Right 
Ventricle in Adults With Congenitally Corrected 
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Transfer of a Soluble TGF-Beta Type II Receptor 
Inhibits Neointlma in a Porctne C&onary Art&y After 
Stenting 1201-I l&307* 
Circulating Tumor Necrosis Factor-Alpha and Matrix 
Metalloprotelnase Activities in Patients With 
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Extracorporeal circulation 
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Cerebral Perfusion During the Norwood Procedure 
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Can Chansw Referral Patterns Based on ACCIAHA 
PracticeGuidelines for Coronary Angiography Be 
Measured? Validation of a Decision Analvsis Model of 
Test Appropriateness I” Coronary Arter; Disease 
Patients 1095.56.526A 
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Myocardium 
Aspirin Protects Cardiac Myocytes From Apoptosis by 
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Natriuretic Peptide A Receptor Is Associated With 
Improved Diastolic Function in Presence and 
Absence of Pressure Overload Hypertrophy 
1158.71.193A 
Chronic Subcutaneous Administration of the Cardiac 
Peptide BNP in Experimental Heart Failure Does Not 
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Nitroglycerin: Real-Time Myocardial Contrast 
Echocardiographic Study 1043-50.414A 
Nitric oxide 
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Score in Elderly Patients 1112.86.180A 
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Compared to the Primary Angioplasty With 
Thrombectomy Dewce in Acute Myocardial InfarctIon 
Patients 1049-l 12.343A 
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Prediction of All-Cause and Cardiovascular Mortality: 
The Strong Heart Study 1115-6.108A 
Risk Stratification and Prognosis in Octogenarians: A 
Stress Echocardiographic Study 1019.34409A 
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Aspltin on 30.Day Mortality in Patients With Acute 
Myocardial Infarction 1071-l 06.346A 
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Than lntraortic Balloon Pumping 120%67.215A 
The Role of Cardiac Power and Systemic Vascular 
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Pulmonary &nbolism: Changes Aner Treatment 
100%127.224A 
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Circardian Variation of QT Dispersion Determined by 
Twelve-Lead Halter Electrocardiography in Patients 
WIthout Coronary Artery Disease 1213-9.136A 
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Intravascular Radiation in a” Atherosclerotic Rabbit 
Model 1152-125.264A 
Inflammatory Mechanisms of Dilative Remodeling After 
lntracoronarv Beta Radiotheraiw 1099-l 95.38A 
lntracoronary &i-Irradiation 24 pours After 
Percutaneous Coronary Interventions: A Serial 
Volumetric Intravascular Ultrasound Study 
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808-4.34A 
Echocardiography: Prevalence and-Relationship to 
Clinical Outcome 1019.32.406A 
Preinterventional Levels of C-Reactive Protein and 
Platelet Function in Patients With Stable Angina 
1175-l 78.64A 
Primary Use of the Cuttmg Balloon Results in Fewer 
Major Adverse Cardiovascular Events at Six Months 
Than Balloon Angioplasly in a Subgroup of Patients 
With OstiaVBifurcation or Small Vessel Lesions 
1005A-217.5A 
Angiographic and Hemodynamic Correlates of 
Low-Dose Positive Dobutamine Stress 
Echocardiography 1092.48.427A 
Application of a Novel Ultrasound Transducer for 
Continuous Monitoring Treadmill Exercise Stress 
Echocardiography: Utility in the Detection of 
Coronary Artery Stenosis 1117-35.434A 
Can Myocardial Contrast Echocardiography, Ustng 
Triggered Replenishment Imaging, Be an Alternate to 
Sinale-Photon Emission Computed Tomoaraohv in 
Pre&cting Significant CoronaLy Artery Dis&ie? 
1117-43.436A 
The Endothelial Nitric Oxide Synthase (Glu298Asp and 
-788T>C) Gene Polymorphisms Are Associated With 
Coronary In-Stent Restenosis 1078-183.32A 
The Frequency and Consequences of Angiographic 
Aneurysms After Sirolimus-Eluting Stems: Results 
From SIRIUS 1030.181.13A 
The Impact of Sirolimus-Elutina Stents in Diabetics: 
Cardiac Troponin I Release After Dobutemine Stress 
Echocardiography in Patients With Coronary Artery 
Disease 1092-45.426A 
Change in Doppler Left Ventricular Inflow Pattern by 
Leg Lifting Maneuver Unmasks Diastolic Dysfunction 
in Hypertensive Patients With Diabetes 
1066-33.42OA 
Delay in Transition From Seamental Contraction to 
Results From the SIRIUS T&l 839FO-8.54A 
The Impact of Sirolimus-Eluting Stents on the Outcome 
of Patients With Bifurcation Lesions 1030.180.12A 
The Volume of Embolic Particles Retrieved via Distal 
Prolonged Antiplatelet Therapy After Coronary 
Brachytherapy: When Is It Safe to Stop Clopidogrel? 
1128.183.49A 
Qualitative Assessment of Coronarv Lesions Treated 
With Sirolimus-Eluting Stents: S&al Intravascular 
Ultrasound Analysis From the SIRIUS Trial 
877.4.81A 
Randomized Intravascular Ultrasound Comparcson 
Between Patients That Underwent Amorphous 
Hydrogenated Silicon-Carbide Coated Stent 
Deployment Versus Uncoated Stents 1150.184.56A 
Protection Is Similar With Either Occlusion Balloon or 
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Saphenous Vein Graft Interventions 1129-174.50A 
Three-Dimensional Intravascular Ultrasound 
Assessment After the Implantation of 
Estrogen-Eluting PC-Coated Stems in Human 
Coronary Arteries 1006-176.5A 
Three-Year Clinical and Quantitative Angiographic 
Follow-Up After Carotid Artery Stenting 
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R&xatlon Activity (TT) Reliably Predicts Changes in 
Myocardial Pelfusion During Dobutamlne Stress 
884s1.470A 
Delayed Revascularization Has an Adverse Effect on 
Outcome in Patients With Viable Myocardium 
1108.28.564A 
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Myocardial Segments 843-8.453A 
Stress Echocardiography in the Evaluation of Women 
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Analysis 884-5.471A 
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Stroke 
Acute and Long-Term Thromboembolic Events In 
Patients With Atrial Tachyarrhythmias: Comparison 
Behveen Atrial Fibrillation, Atrial Flutter Plus Atrial 
Fibrillatron, and Pure Atrial Flutter 1210-l .130A 
An Endovascular Approach to Stroke Prevention in 
Atrial Fibrillation: Results of the Multicenter 
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Transcatheter Occlusion) Feasibility Trial 
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Endarterectomy 1129-197.51A 
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Outcomes 1005-192.2A 
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1090.2.lMlA 
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1180-l 54.3OOA 
Coronary Endothelial Dysfunction Is Associated With 
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1103.129.26OA 
Delays in Revascularization Are Associated With en 
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Infarctron 1071-l 10.347A 
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Prevalen& and Association With Pulmonary Edema 
1207~85.214A 
Duration of Cardiopulmonary Bypass and Risk of 
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Surgery Operations 871-3.539A 
Factor V L&den Mutatron Is Associated With Increased 
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Carotid Stenting 1129-177.51A 
Frequency, Severity, and TechnIqueDependency of 
lnteratrial Contrast Shunting: A Prospective 
Population-Based Transesophageal 
Echocardioaraohic Studv 1018-28.406A 
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Stroke With Acute Myocardial Infarction 
1146-l 12.375A 
Intra- and Post-Operative Treatment and Course 
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1144-58.53OA 
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Recent Cardiovascular Event? 1126-102.367A 
Is Surgical Closure of the Left Atrial Appendage Useful 
for Preventing Cardioembolic Events? 1214.40463A 
Is There an Incremental Value of Contrast 
Transesophageal Echo to Assess Intracardiac Shunt 
in Patients With Negative Contrast Transthoracic 
Echo? 1214-46.464A 
Is Transesophageal Echocardiography Necessary for 
Cardiac Source of Embolus in Patients With Sinus 
Rhythm and Without Structural Heart Drsease? 
1018~29.466A 
lschemic Stroke Causes Regional Denervation in Rat 
Myocardium 1142.42.444A 
Left Atrial Size and Rusk of Stroke in American Indians 
Free of Clinical Cardiovascular Disease 852-3.459A 
Libman-Sacks Vegetations Are Associated With 
Cerebrovascular Disease in Patrents With Systemic 
Lupus Erythematosus 870-3.466A 
Low Stroke Rates During Carotid Artery Stenting With 
Neuroprotection 1129-l 73.5OA 
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Incident Stroke in American Indians Free of Clinical 
Cardiovascular Disease 841-3.510A 
Outcomes From Carotid Artery Stenting in Over 1,000 
Cases From a Single Group of Operators 868.2.79A 
Paradoxrcal Increase in Strokes in the Randomized 
Trials on Rate Versus Rhvthm Control in Atrial 
Fibrillation 1210.19.13OA 
Percutaneous Left Atrial Appendage Transcatheter 
Occlusion (PLAATOTM) to Prevent Stroke in Patients 
With Atrial ‘Fibrillation: ‘Initial Results of the 
Multicenter Feasibilitv Trial 868-1.79A 
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Patients With Neurocardiogenic Injury 1142.43.444A 
Plasma Levels of Inflammatory C-Reactive Protein and 
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Recurrent lschemic Cerebral Events in Patients With 
Different Subtypes of Arterial or Cardiac Source of 
Embolism: A Four and Five-Year Follow-Up Study 
1214-36.462A 
Results of U.S. Phase I Clinical Trial of Closure of 
Patent Foramen Ovale Associated With Stroke/ 
Transient lschemic Attack or Peripheral Embolism 
Usina the Amolatzer@ Patent Foramen Ovale Device 
1199:173.75A 
Secondary Prevention of Cerebrovascular Events in 
Patients With Patent Foramen Ovate and Cryptoaenrc 
Stroke: AUSTRIAN-PFO-Registry 891-5.4961\- 
Sinale Center Exoerience With Transcatheter Patent 
F&amen Ovald Closure for Paradoxical Embolism 
1021-l 60.473A 
The Canadran Registry of Atrial Frbrillation: Lack of 
Prognostic Differences Between Atrial Fibrillation and 
Atrial Flutter 803-1.102A 
The Detection of Left Atrial Thrombi in Patrents With 
Atrial Fibrillation Were Associated With 
Thromboembolic Events During Long-Term 
Follow-Up 803-3.103A 
The Modifying Effect of Age on Risk Factors for Stroke: 
The Manitoba Follow-Up Study 887FO-5.220A 
Time Course of Morbidity and Mortality After a 
Myocardial Infarction Complicated by Left Ventricular 
Systolic Dysfunction or Heart Failure 1217.56.536A 
Tissue Factor Pathway rn Carotid Atherosclerotic 
Plaques: Relationships With Clinical Patterns and 
Risk Factors 1032-l 27.232A 
Value of Routine Halter Screenrng for the Detection of 
Paroxysmal Atrial Fibrillation in Patients With 
Cerebral lschemic Attacks 1169-54.531A 
Stroke volume 
Forward Stroke Volume Is Preserved During Left 
Ventricular Remodeling After Mitral Valve Repair 
1204-26.515A 
Sudden death 
A Multicenter Study of Heart Failure as a Predictor for 
Internal Cardioverter Defibrillator Shocks 
10641.95A 
Chronic Subthreshold Electrical Stimulation of the Left 
Stellate Ganglion and a Canine Model of Sudden 
Cardiac Death 
825s4.112A 
Factors Associated With Increased Risk of Sudden 
Death in Youna Patients With Hvoertroohic 
Cardiomyopathy 1014-87.147A’ 
Implantable Cardioverter Defibrillator Lead 
Complications and Laser Extraction in Children and 
Young Adults With Congenital Heart Drsease 
873-2.137A 
Implication of MADIT-II on Unselected Patients 
Following en Acute Myocardial infarction 1064.296A 
Nuclear Perfusion Scintigraphy es a Gatekeeper for 
Implantable Cardioverter Defibrillation lmplantatron 
858.5.46lA 
Prolonged QRS Duration and Cardiac Death in 
Postinfarction Patients 1213.3.134A 
Sex Selection in Unexplained Sudden Cardiac Death 
1016.1267A 
Short QT: A New Electrocardioaraohic Pattern Related 
to Familial Sudden Death 8i8-3.105A 
Successfullv Teachino of Earlv Defibrrllation in Primarv 
School Children U&g a Self Instruction Video 
1027.93.337A 
’ 
Time Course of Morbidity and Mortality After a 
Myocardial Infarction Complicated by Left Ventricular 
Systolic Dysfunction or Heart Failure 1217.56636A 
Superoxide dismutase 
Angiotensin II Type-l Receptor AntagonIst Inhibits 
Vascular Phenotypic Change and Remodeling in 
lntramyocardial Arteries by Reducing Oxidative 
Stress Through Upregulation of Superoxide 
Dismutase 1177-l 29.294A 
Supraventricular tachycardia 
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Lono-Term Outcome Aftdr Ablation of Postooerative 
A&al Reentrant Tachycardias Is Compli&ed by 
Atrial Fibrillation 1163.5.119A 
Magnetic Navigation System for Intracardiac Mapping 
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631.4.457A 
Myocardial Acceleration During lsovolumic Contraction 
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Pulmonary Valve Replacement in the Restricted 
Right Ventricle of Repaired Fallot Patients 
831.6.457A 
Surgical Correctton of Tetralogy of Fallot in Adults in the 
Current Era 1059-160.455A 
The Use of Helical Cardiac Tomography and 
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A High-Grade Stenosis After Successful Fibrinolysis 
Does Not Predict Death and Reinfarctfon: IO-Year 
Follow-Up of the APRICOT-l Trial 822-2.35OA 
Clinical Outcome After Prehospital Thrombolysis 
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Patients With Acute Myocardial Infarction? 
1071-116.345A 
Female Gender Is the Strongest Predictor of Major 
Hemorrhage III Trials of Combination of Fibrinolytic 
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